Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Suelen da Silva Gomes Dias(Fundação Oswaldo Cruz), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Thiago Moreno L. Souza(National Institute of Science and Technology), Pedro Paulo de Abreu Manso(Fundação Oswaldo Cruz), Ester A. Barreto, Carolina Q. Sacramento(National Institute of Science and Technology), Isaclaudia G. Azevedo-Quintanilha(Fundação Oswaldo Cruz), Lívia Teixeira(Fundação Oswaldo Cruz), Natalia Fintelman‐Rodrigues(Fundação Oswaldo Cruz), Fernando A. Bozza(D’Or Institute for Research and Education), Eugênio D. Hottz(Universidade Federal de Juiz de Fora), Jairo R. Temerozo(Fundação Oswaldo Cruz), Camila R. R. Pão(Fundação Oswaldo Cruz), Dumith Chequer Bou‐Habib(Fundação Oswaldo Cruz), Mayara Mattos(Fundação Oswaldo Cruz), Vinícius Cardoso Soares(Universidade Federal do Rio de Janeiro), André C. Ferreira(Fernando Pessoa University), Caroline S. de Freitas(Fundação Oswaldo Cruz)
Cited by 33
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527